SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Z. Permutt, T.-A. Le, M. R. Peterson, E. Seki, D. A. Brenner, C. Sirlin, R. Loomba, Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD, Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  2. 2
    Eric R. Kallwitz, Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?, Hepatology International, 2012,

    CrossRef

  3. 3
    Jérôme Boursier, Marie-Christine Rousselet, Christophe Aubé, Paul Calès, Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice, Expert Opinion on Medical Diagnostics, 2012, 1

    CrossRef

  4. 4
    Ryuta Shigefuku, Hideaki Takahashi, Minoru Kobayashi, Hiroki Ikeda, Kotaro Matsunaga, Chiaki Okuse, Nobuyuki Matsumoto, Shiro Maeyama, Shigeru Sase, Michihiro Suzuki, Fumio Itoh, Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?, Journal of Gastroenterology, 2012,

    CrossRef

  5. 5
    Matthew J. Armstrong, Diarmaid D. Houlihan, Louise Bentham, Jean C. Shaw, Robert Cramb, Simon Olliff, Paramjit S. Gill, James M. Neuberger, Richard J. Lilford, Philip N. Newsome, Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort, Journal of Hepatology, 2012, 56, 1, 234

    CrossRef

  6. 6
    Phunchai Charatcharoenwitthaya, Keith D. Lindor, Paul Angulo, The Spontaneous Course of Liver Enzymes and Its Correlation in Nonalcoholic Fatty Liver Disease, Digestive Diseases and Sciences, 2012,

    CrossRef

  7. 7
    Stefano Ballestri, Amedeo Lonardo, Dante Romagnoli, Lucia Carulli, Luisa Losi, Christopher P. Day, Paola Loria, Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD, Liver International, 2012, 32, 5
  8. 8
    Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt, MacSween's Pathology of the Liver, 2012,

    CrossRef

  9. 9
    J. K. Dowman, M. J. Armstrong, J. W. Tomlinson, P. N. Newsome, Current therapeutic strategies in non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2011, 13, 8
  10. 10
    Shefali Agrawal, Cherag Daruwala, Metabolic syndrome and hepatic resection: improving outcome, HPB, 2011, 13, 12
  11. 11
    Perry J. Pickhardt, Seong Ho Park, Luke Hahn, Sung-Gyu Lee, Kyongtae T. Bae, Eun Sil Yu, Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis, European Radiology, 2011, 22, 5, 1075

    CrossRef

  12. 12
    Neeraj Bhala, Paul Angulo, David van der Poorten, Eric Lee, Jason M. Hui, Giorgio Saracco, Leon A. Adams, Phunchai Charatcharoenwitthaya, Joanne H. Topping, Elisabetta Bugianesi, Christopher P. Day, Jacob George, The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study, Hepatology, 2011, 54, 4
  13. 13
    Angel Brea Hernando, José Puzo Foncillas, Enfermedad del hígado graso no alcohólico y riesgo cardiovascular, Clínica e Investigación en Arteriosclerosis, 2010, 22, 6, 259

    CrossRef

  14. 14
    Julien Calderaro, Elie Serge Zafrani, Stéatopathie hépatique non alcoolique, Annales de Pathologie, 2010, 30, 6, 413

    CrossRef